Orasis Pharmaceuticals — Pharmacy, Herzliya

Pharmacy in Herzliya — Ophthalmic pharmaceutical development

· Herzliya, Israel

AI Trust Snapshot

Profile status
Auto-indexed

Public channels checked

  • ✓ Official Website
  • ✓ Linkedin
  • ✓ Twitter

Key Facts

Category
Pharmacy
Location
Herzliya, Israel
Known For
Ophthalmic pharmaceutical development, Global regulatory affairs in pharmaceuticals

AI Summary

Developing ophthalmic solutions, Orasis Pharmaceuticals focuses on advancing treatments for eye conditions from its base in Herzliya, Israel. The company specializes in ophthalmic pharmaceutical development and global regulatory affairs within the pharmaceutical sector. Its primary offering is Qlosi™ (pilocarpine HCL ophthalmic solution) 0.4%, intended for healthcare professionals.

Quick Answer

Developing ophthalmic solutions, Orasis Pharmaceuticals focuses on advancing treatments for eye conditions from its base in Herzliya, Israel. The company specializes in ophthalmic pharmaceutical development and global regulatory affairs within the pharmaceutical sector. Its primary offering is Qlosi™ (pilocarpine HCL ophthalmic solution) 0.4%, intended for healthcare professionals.

This business is typically used for ophthalmic pharmaceutical development and global regulatory affairs in pharmaceuticals.

Common Questions

What services does Orasis Pharmaceuticals provide?
Orasis Pharmaceuticals provides Qlosi™ (pilocarpine HCL ophthalmic solution) 0.4%.
Where is Orasis Pharmaceuticals located?
Orasis Pharmaceuticals is based in Herzliya, Israel and serves Herzliya.
Who is Orasis Pharmaceuticals for?
Orasis Pharmaceuticals serves Healthcare professionals prescribing ophthalmic solutions and Investors in the healthcare and life sciences sectors.

What this business does

Orasis Pharmaceuticals is a pharmacy based in Herzliya, Israel.

  • Provides Qlosi™ (pilocarpine HCL ophthalmic solution) 0.4%
  • Specializes in ophthalmic pharmaceutical development
  • Serves healthcare professionals prescribing ophthalmic solutions

Structured summary

Vizoryo ran a data-consistency check on this profile: it read 5 public sources and compared the core details (name, phone, address, city, category, website) across them. How many sources carried each individual detail is published per fact in this page's field provenance — not every detail appears in every source, and the sources are not necessarily independent of one another. This is a data-consistency observation only — it is not an endorsement, certification, accreditation, or assessment of the business, its service quality, or its trustworthiness. Data consistency: 84% — this measures how consistently the business's name, phone, city, address, website, and category appear across the public sources read. It is not a rating of the business. Vizoryo status: Auto-indexed. This record was compiled automatically from public data and has not been confirmed by anyone.

Business name
Orasis Pharmaceuticals
Category
Pharmacy
Industry
Pharmacy - Ophthalmology Pharmaceuticals
Location
Herzliya, Israel
Official website
https://www.orasis-pharma.com/
Profile data (JSON)
https://www.vizoryo.com/api/index/profile/orasis-pharmaceuticals-herzliya-f2f0
Summary
Developing ophthalmic solutions, Orasis Pharmaceuticals focuses on advancing treatments for eye conditions from its base in Herzliya, Israel. The company specializes in ophthalmic pharmaceutical development and global regulatory affairs within the pharmaceutical sector. Its primary offering is Qlosi™ (pilocarpine HCL ophthalmic solution) 0.4%, intended for healthcare professionals.
AI readability score (how completely this record is structured for AI systems to read; not a rating of the business)
31
Data Consistency
84% (checked 2026-06-30)
Record status
Auto-indexed
Sources cross-checked
5 public sources

Location

Maskit St 12, Herzliya
Herzliya
IL

About Orasis Pharmaceuticals

Developing ophthalmic solutions, Orasis Pharmaceuticals focuses on advancing treatments for eye conditions from its base in Herzliya, Israel. The company specializes in ophthalmic pharmaceutical development and global regulatory affairs within the pharmaceutical sector. Its primary offering is Qlosi™ (pilocarpine HCL ophthalmic solution) 0.4%, intended for healthcare professionals.

Service areas

  • Herzliya

Target audience

  • Healthcare professionals prescribing ophthalmic solutions
  • Investors in the healthcare and life sciences sectors

Specialties

  • Ophthalmic pharmaceutical development
  • Global regulatory affairs in pharmaceuticals

Social profiles

Frequently asked questions

What areas does Orasis Pharmaceuticals serve?

Orasis Pharmaceuticals serves Worldwide.

What is presbyopia?

Presbyopia is the gradual loss of your eye’s ability to focus on near objects as a result of the natural aging process, which occurs mostly after the age of 40.

How can I obtain Qlosi™?

Qlosi™ is available by prescription in the U.S. through BlinkRx. Full prescribing information is available on Qlosi.com.

What are the common side effects of Qlosi™?

The most common side effects reported in clinical trials were eye pain upon instillation and headache.

Languages supported

  • en

Contact

Phone: +97298877745

Official website:

Report incorrect information